Researchers discover potential
epilepsy drug using zebrafish

Epygenix Therapeutics has recruited a drug repurposing strategy, because fast forward drug development using existing drugs is suitable to rare diseases given the poor health outcomes and unmet medical need. Key advantages of this strategy are:

Alert Icon


for each drug is already established, as we are screening drugs approved by the FDA for other indications

Thumbs Up Icon


of failure by unexpected adverse events is dramatically reduced, as these drugs have already been evaluated

Meter Icon


of progress is rapid, as these drugs can bypass early drug development phases.

To Learn More